Applied Regenerative Technologies is an Arlington-based biotechnology company focusing on restoring nerve function after trauma, tumor resection, or neurological disease. Their novel products are bioengineered to control the regeneration of nerves, and were developed by a coordinated effort between physicians and scientists. This synergy has resulted in a nerve implant that mimics the natural nerve structure, and achieves functional recovery in nerve gaps of up to 3 cm. When compared to current market options, the company’s products are categorically superior and will improve the clinical outcomes for hundreds of thousands of patients per year around the world. In our most recent preclinical trials, Applied Regenerative Technologies tested a next generation product that drastically increases regeneration of nervous tissue and helped restore motor and sensory function. To bring this product to market, the company established worldwide partnerships for product development, advanced manufacturing, and clinical testing with the ultimate goal of improving the quality of life for those with nerve injuries.